Search
Filter Results
Displaying 381–390 of 896 results for “vision connection”
-
Jun 27, 2015
VISIONS 2015 — Dr. José Sahel Receives Foundation's Most Prestigious Research Honor
Research NewsFor those of us supporting the drive for vision-saving treatments and cures, he’s exactly the type of person we want on our team.
-
Sep 10, 2014
Ready for the Spotlight: Rebecca Alexander Shares Her Story of Living with Usher Syndrome
Beacon Stories“…the best thing is to reach out and network, and access all the resources. The more invested you are in what’s out there, the more you get back.”
-
Jan 29, 2014
The Power of Suggestion — Challenges of the Placebo Effect
Research NewsEven in a well-designed clinical trial, the placebo effect can rear its head.
-
Dec 2, 2013
An FFB Board Member’s Perspective on Her Experience with Acupuncture
Beacon StoriesMoira Shea describes her experience with acupuncture.
-
Sep 26, 2013
New Imaging Technique May Be Game-Changer for RP Clinical Trials
Research NewsKnown as EZ Width, it holds potential for reducing the time, cost and number of patients needed to determine if a therapy is working in a clinical trial.
-
Apr 17, 2013
A New Therapeutic Trick for Old Dogs
Research NewsA New Therapeutic Trick for Old Dogs
-
Nov 2, 2012
Turning Stem Cells Into "Super" Models
Research NewsScientists have found a way to take a small skin or blood sample from a patient, turn back the clock on those sample cells so they become stem cells, and then coax them forward to become photoreceptors, or any other cell type in the body.
-
Mar 19, 2012
Beacon StoriesWhen it comes to describing Eric Fulton, “gregarious” is a more-than-appropriate adjective for the husband and father of two who, fittingly, is also communications manager at the Bethesda-based Clark Construction Group. “It comes naturally to me,” he says of his ability to mix it up with people. “The cause makes it easier. But, otherwise, I’m pretty outgoing; I like to talk to people. It’s what I do.”
-
Mar 2, 2012
Foundation Commits $2 Million to Development of a Cross-Cutting Drug Treatment
NewsMitoChem Therapeutics has identified three compounds that appear to boost mitochondrial function and, thus, show potential for slowing vision loss caused by a variety of retinal degenerations.
-
Oct 4, 2011
Gene Therapy Revives Cones Long After They Stop Working
Research NewsA Foundation-funded research group is developing a gene therapy that revives degenerating cones, enabling them to regain their ability to respond to light and provide vision.